Marit Synnestvedt

发表

Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer

Daehoon Park, B. Naume, T. Sauer, 2017, Breast Cancer Research and Treatment.

Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

Therese Sørlie, Gunnar Kvalheim, Rolf Kåresen, 2007, Molecular oncology.

DNA methylation patterns in luminal breast cancers differ from non‐luminal subtypes and can identify relapse risk independent of other clinical variables

Vinay Varadan, Nevenka Dimitrova, Angel Janevski, 2011, Molecular oncology.

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness

J. Nesland, B. Naume, K. Giercksky, 2012, Histopathology.

Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.

B. Naume, T. Risberg, I. Mjaaland, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy

J. Nesland, R. Kåresen, H. Russnes, 2013, Acta oncologica.

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

B. Naume, G. Mellgren, I. Mjaaland, 2020, Molecular oncology.

Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study

J. Nesland, B. Naume, T. Risberg, 2012, BMC Cancer.

Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern

B. Naume, J. Nesland, K. Pantel, 2011, Breast Cancer Research and Treatment.

Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis

T. Fehm, B. Naume, J. Nesland, 2011, Clinical Cancer Research.

The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

L. V. van't Veer, H. Russnes, L. Baumbusch, 2011, Breast Cancer Research.

The prognostic significance of tumor cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

H. Russnes, L. Baumbusch, B. Naume, 2011 .

The prognostic impact of occult nodal metastasis in early breast carcinoma

R. Kåresen, Daehoon Park, B. Naume, 2009, Breast Cancer Research and Treatment.

NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients

P. Lønning, B. Naume, E. Schlichting, 2018, Breast Cancer Research.

Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination

J. Nesland, B. Naume, K. Giercksky, 2008, Clinical Cancer Research.

Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.

J. Nesland, B. Naume, K. Giercksky, 2012, Histology and histopathology.